Related Experiment Video
Updated: Jun 8, 2026
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Medical marijuana 2010: it's time to fix the regulatory vacuum
1Georgetown University Law Center, Washington, D.C.
Summary
This study reviews the history and politics of medical marijuana, highlighting its proven efficacy and safety for specific conditions. It calls for regulatory reforms to align state laws with federal standards for controlled substances.
Area of Science:
- Pharmacology and Therapeutics
- Public Health Policy
- Medical Cannabis Research
Background:
- Historical classification of marijuana as a banned substance.
- Political landscape influencing medical marijuana research.
- Existing state statutes for medical marijuana are often ambiguous.
Purpose of the Study:
- To examine the history and politics surrounding medical marijuana.
- To present evidence on the efficacy and safety of Cannabis for specific pathologies.
- To analyze current state statutes and propose regulatory reforms.
Main Methods:
- Historical analysis of marijuana's legal status.
- Review of scientific literature on Cannabis efficacy and safety.
- Statutory analysis of state-level medical marijuana laws.
- Policy analysis and recommendations for regulatory reform.
Main Results:
- Evidence supports the scientifically demonstrated efficacy and safety of Cannabis for certain pathologic conditions.
- Vaguely worded state statutes create potential for abuse in recommendation, distribution, and use.
- Discrepancies exist between state oversight and federal regulation of controlled substances.
Conclusions:
- Regulatory reforms are needed to standardize state oversight of medical marijuana.
- Proposed reforms aim to align state regulations with federal standards for controlled substances.
- Ensuring consistent and stringent regulation is crucial for safe medical utility.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:27Hallucinogens and Psychedelics
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).